Managers
Financial services provider iBanFirst, which delivers solutions across banking borders, has secured a growth equity investment to fund product development, international expansion and M&A, from global private equity firm Marlin, which became the fintech’s largest shareholder as a result, replacing existing business angels and some of the company’s early backers.
Through the transaction, a number of iBanFirst’s historic partners, including top-tier venture capital firm Elaia, Bpifrance Large Venture and Xavier Niel, have strengthened their existing commitments. iBanFirst CEO and Founder, Pierre-Antoine Dusoulier, will become the company’s second-largest shareholder as part of the new agreement.
The move marks a shift
Varagon Capital Partners (Varagon) is serving as Administrative Agent, Joint Lead Arranger, Joint Bookrunner and Syndication Agent on a senior secured credit facility to support the acquisition of JTM Foods, LLC (JTM) by Tenex Capital Management (Tenex).
Headquartered in Erie, PA, JTM Foods, LLC, has been producing premium quality snack pies and other sweet treats since 1985.
The Company produces JJ’s Bakery branded, co-manufactured, and private label sweet baked goods such as fruit filled snack pies, mini pies, and crispy rice treats.
MediSpend, a global technology company providing solutions for the life sciences industry, has secured a majority investment from Susquehanna Growth Equity (SGE), an entrepreneur-centric growth equity firm exclusively focused on software and information services companies.
SGE’s prior investments across the broader healthcare vertical include Evive, HMP Global, iContracts, MMIT, ProviderTrust and RLDatix. Financial terms of the investment were not disclosed.
MediSpend provides solutions for the life sciences industry, enabling some of the world’s largest pharmaceutical, medical device and emerging biotech companies to compliantly manage high-risk business functions through top-rated software and client services. The MediSpend Global Compliance Suite represents
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, a specialist in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm.
The pending transaction is expected to close in the second quarter of this year, subject to the satisfaction of regulatory approval and customary closing conditions. Financial details were not disclosed.
Founded in 2008, Greenphire enables pharmaceutical industry leaders worldwide to run more efficient and successful clinical trials. The company’s end-to-end solutions optimise clinical trial performance by streamlining
Medtanken, a leading primary care group in Western Sweden and a portfolio company of Procuritas Capital Investors VI (Procuritas), has successfully made its first step into the specialist care sector by acquiring Citysjukhuset.
With its passion for building strong sustainable businesses through transformational growth, Procuritas is facilitating accelerated development and multi-regional and digital expansion of the group. Today’s expansion follows last month’s news of Medtanken’s first bolt-on growth acquisition of Kvarterskliniken.
Medtanken has a vision of delivering and enhancing quality primary care provision in Sweden and today it also announces the successful launch of a new app offering a digi-physical
Pathway has closed on a USD400 million customised fund of funds (FOF) for an Asia-based institutional investor.
The fund will seek to build a diversified portfolio of primary fund investments and co-investments in both the small and middle markets globally.
The fund represents a continuation of Pathway’s successful 30-year history of investing in private markets, which totals more than USD95 billion in commitments. To date, Pathway has developed more than 95 customised solutions for our clients across private equity, private credit, and infrastructure mandates.
Novo Holdings has co-led with Vivo Capital the over-subscribed USD200 million Series A and Crossover round in Esco Lifesciences Group (Esco), a leading provider of life sciences tools and services.
A new venture investment business has been formed via a partnership between the city advisory group Forster Chase and four successful CEOs/entrepreneurs, designed to guide and turbo charge young companies through to highly valuable exits.
Forster Chase Ventures, in conjunction with the other companies in the group (Forster Chase Executive Search, Forster Chase Corporate Finance) will create significant value for founders and shareholders by delivering exceptional strategy, people, distribution and capital solutions. Given the cashflow challenges that young businesses often face, this will be a cost-effective model that is focused on long term mutual success and growth.
Over multiple years
FFL Partners, a San Francisco-based private equity firm, Caisse de dépôt et placement du Québec (CDPQ), a global investment group, and the Dr H Doug Barnes Family have acquired all of the outstanding Class A common shares of the New Look Vision Group Inc for USD50.00 in cash per Share, other than certain Shares held by certain shareholders who received consideration consisting of common shares of the purchaser.
“We look forward to working together with our new partners to take New Look Vision to the next level of growth and add value for our customers, partners and employees across North
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
Shining brighter in light of global change
Shining brighter in light of global change